Advertisement

FDA begins process that could authorize Pfizer vaccine for 5-11 year olds

05:20
Download Audio
Resume

On Tuesday, a Food and Drug Administration advisory panel debates whether to recommend the Pfizer COVID-19 vaccine to kids between ages 5 to 11. Full authorization could come by the end of the week.

We get the latest from NPR's Allison Aubrey.

This segment aired on October 26, 2021.

Related:

Advertisement

More from Here & Now

Listen Live
Close